Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision

Current ovarian cancer screening guidelines in high-risk women vary according to different organizations. Risk reducing surgery remains the gold standard for definitive treatment in BRCA mutation carriers, but research advancements have created more short-term options for patients to consider. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Kelsey E., Lu, Karen H., Klimczak, Amber M., Mok, Samuel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836089/
https://www.ncbi.nlm.nih.gov/pubmed/29466291
http://dx.doi.org/10.3390/cancers10020057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836089/
https://www.ncbi.nlm.nih.gov/pubmed/29466291
http://dx.doi.org/10.3390/cancers10020057

Ejemplares similares